Hydrostasis will present its wearable hydration monitoring solution that provides actionable, real-time and personalized hydration information to impact performance, health and safety.
San Diego, CA, January 7, 2020 – Hydrostasis, today announced that it has scheduled a company presentation at Digital Medicine & Medtech Showcase™ 2020, to be held January 13–15, during the most important week in healthcare at the Parc 55 in San Francisco.
Debbie Chen, Founder & CEO will be presenting Hydrostasis at the Digital Medicine & Medtech Showcase as follows:
Date: Wednesday, January 15, 2020
Time: 10:45 AM (PST)
Room: Parc 55/Balboa, Level 4
Venue: Parc 55 – A Hilton Hotel, 55 Cyril Magnin Street, San Francisco, CA
Hydrostasis is creating a new category establishing personalized, real-time continuous hydration monitoring as a standard of care in sports and healthcare. Our innovative solution will be a major disruptor to legacy hydration measurement products. The Hydrostasis hydration monitoring solution includes a wearable sensor that collects hydration data, the data is analyzed using proprietary algorithms, and displayed via the Hydrostasis cloud platform with actionable dashboards, mobile applications, alert notifications and comprehensive reports. Our beachhead target market is collegiate sports teams which will pave the way to at-home healthcare, where our solution could save an estimated $70B in hospitalization costs related to patients with chronic heart failure and chronic kidney disease. We are very excited with the valuable and compelling customer feedback we have received and strong interest we’ve seen for our product. Our target is to complete product beta testing in 2020.
“We are excited for the opportunity to present our Hydrostasis wearable hydration monitoring solution at the Digital Medicine & Medtech Showcase,” said Debbie Chen, Founder & CEO of Hydrostasis. “We look forward to sharing our business and our market-changing innovative solution with all the executives and investors attending the event.”
Digital Medicine & Medtech Showcase, produced by Demy-Colton and EBD Group, is an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year during the course of one of the industry's largest gatherings and busiest weeks.
“We are delighted that Hydrostasis will be presenting at Digital Medicine & Medtech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “This is the perfect platform for digital medicine and medtech companies to showcase their innovation and seek out their next deal.”
